Document:

exv4w33

 

EXHIBIT 4.33

Second Amendment 

To The

Savings & Profit Sharing Plan for Employees of

First Interstate BancSystem, Inc.

     1. Recitals. Section 12.1 of the Savings & Profit Sharing Plan for Employees
of First Interstate BancSystem, Inc. (the “Plan”) gives First Interstate BancSystem, Inc., as the
Plan Sponsor, the right to amend the Plan at any time. On July 26, 2006, the Board of Directors of
the Plan Sponsor delegated authority to the First Interstate BancSystem, Inc. Benefits Committee
(the “Committee”) to take any action with respect to the Plan to the extent that such action does
not result in additional funding obligations for the Plan Sponsor. The Committee hereby amends the
Plan to revise the timing of forfeitures and to change the maximum investment in stock.

     2. Amendment of Plan. The following Amendment to the Plan is adopted effective July
1, 2007, unless otherwise provided.

     (A) The first paragraph of Section 5.4 of the Plan shall be amended to read as follows:

	 	5.4	 	Forfeiture of Nonvested Amounts. If any portion of a
Member’s Account is non-vested upon the Member’s separation from Service, the
non-vested amount shall be retained in such Account until the earlier of the
following events:

	 	(a)	 	no later than the end of the Plan Year in which the Member
receives a distribution of the entire portion of his or her Account
attributable to Employer contributions (which may be nothing if the Member is
not vested); or
	 
	 	(b)	 	the last day of the Plan Year in which the Member first incurs
five consecutive One-Year Breaks in Service.

     (B) Subparagraph (b) in Section 8.2 shall be amended, effective June 1, 2007, to read as
follows:

	 	(b)	 	the maximum investment in Company stock shall, at the time of
the election, in no event exceed 25 percent of the Member’s Account balance
less the Rollover Contributions Account.

     3. Other Provisions. All other provisions of the Plan shall remain unamended and in
full force.

	 	 	 	 	 
	 	 	 
	 	By:  	                                              /s/ ROBERT A. JONES
 	 
	 	 	Robert A. Jones, Chairman 	 
	 	 	Date:     June 28, 2007 	 
	 

 

First Amendment to the Savings & Profit Sharing Plan for Employees of First Interstate BancSystem, Inc.

			
	Prepared by Holland & Hart LLP
	 	06/2007     1exv10w1

 

SETTLEMENT AGREEMENT

     This settlement agreement (“Settlement Agreement”), dated this 14th day of August, 2007, is
entered into by and among Iridex Corporation, a Delaware corporation (“Purchaser”), American
Medical Systems, Inc., a Delaware corporation (“Parent”) and Laserscope, a California corporation
(“Seller” and collectively with Purchaser and Parent, the “Parties”).

     WHEREAS, the Parties are party to an Asset Purchase Agreement dated November 30, 2006 (the
“Purchase Agreement”) pursuant to which Purchaser acquired from Seller certain assets related to
Seller’s aesthetics business. All capitalized terms used herein and not otherwise defined shall
have the meanings ascribed such term in the Purchase Agreement.

     WHEREAS, Section 1.5 of the Purchase Agreement contemplates that the purchase price for the
Purchased Assets is to be adjusted after the Closing.

     WHEREAS, in connection with the Purchase Agreement, Purchaser and Seller entered into a
Product Supply Agreement dated January 16, 2007 (the “PSA”) and wish to amend certain terms of such
agreement as more fully set forth herein.

     WHEREAS, the Parties wish to enter into this Settlement Agreement to document their full and
final agreement as to the amount of the adjustment contemplated by Section 1.5 of the Purchase
Agreement, to amend the PSA and to set forth their mutual understanding as to certain other
matters.

     NOW, THEREFORE, in consideration of the promises herein made and other good and valuable
consideration, it is hereby agreed as follows:

1.       Purchase Price Adjustment

	 	(a)	 	The Parties agree that pursuant to the provisions of Section 1.5 of the
Purchase Agreement, Purchaser will make an additional payment to Parent in the amount
of $1,150,000 (the “Adjustment Amount”), as set forth in subsection (b) below, which
will be the sole and final adjustment to the Purchase Price under Section 1.5 of the
Purchase Agreement. There will be no further adjustments to the Purchase Price
relating to the Cash of the Subsidiaries or any other adjustment factor called for
under Section 1.5 of the Purchase Agreement or as a result of the audit of the
historical financial statements of the Aesthetics Business.
	 
	 	(b)	 	Purchaser will pay to Parent the Adjustment Amount by making weekly payments
beginning on August 16, 2007 and continuing on the Thursday of each week thereafter for
one year for a total of 52 payments. The amount of each such payment will be equal to
$22,115.38 (1/52 of the Adjustment Amount). If any scheduled payment date is not a
business day, then the applicable payment will be due on the first business day
thereafter. All payments shall be made by wire transfer of immediately available
funds.

 

 

	 	(c)	 	The parties agree that the initial purchase price allocation set forth in
Schedule 1.6 to the Purchase Agreement is superseded and replaced with
Schedule 1.6 attached hereto.

2.       Product Supply Agreement.

	 	(a)	 	Attached hereto as Exhibit A are purchase orders (the “Purchase
Orders”) from Purchaser for Products (as defined in the PSA), which supersede and
replace in the entirety any and all forecasts or purchase orders previously delivered
by Purchaser under the PSA. Purchaser will not submit, and Seller will not accept, any
further purchase orders or forecasts under the PSA. Seller will build and deliver
Products only pursuant to the foregoing purchase orders. Attached hereto as Exhibit
B is a schedule of Products, hand pieces and service parts (the “Accessories
Purchase Orders”) that Seller will deliver to Purchaser prior to October 16, 2007. All
of the delivery dates set forth in the Purchase Orders and the Accessories Purchase
Orders may be delayed by Seller in its discretion except for the delivery dates related
to the Gemini products; provided, however, that in no event shall such delivery date be
delayed by more than ninety (90) days following the delivery date set forth in such
Purchase Order.
	 
	 	(b)	 	In accordance with the terms of the Letter Agreement between Parent and
Purchaser, dated June 27, 2007, as amended on July 31, 2007 and August 6, 2007 (as so
amended, the “Letter Agreement”), the payment terms for (i) all Products sold to
Purchaser under the PSA and the purchase order attached hereto as Exhibit A,
and (ii) the hand pieces and service parts listed on Exhibit B shall be cash in
advance or via a confirmed letter of credit (with Seller being entitled to immediately
draw on such letter of credit upon shipment of Products), and Section 3.2 of the PSA is
hereby amended to reflect the foregoing. Purchaser will pay to Seller, by wire
transfer in immediately available funds, against outstanding invoices under the PSA,
plus accrued interest, the following amounts: (i) $100,000 on each of August 23, 2007
and August 30, 2007; and (ii) $150,000 on each of September 6, 2007, September 13,
2007, September 20, 2007, and September 27, 2007. The foregoing payment schedule shall
supersede and replace the weekly payment schedule in the Letter Agreement, and Parent
and Seller waive Purchaser’s prior breach of the weekly payment schedule in the Letter
Agreement. Seller will apply these payments first to invoices (both invoiced amount
and accrued interest) that have been outstanding the longest. Purchaser will pay the
remaining balance of all outstanding invoices under the PSA in full, plus accrued
interest, upon the earlier of (a) two (2) business days following the closing of its
contemplated equity financing of approximately $5 million (“Equity Investment”) or (b)
August 31, 2007; provided that, if it shall be a condition to the Equity Financing that
an exemption from the Nasdaq stockholder approval requirements with respect to
issuances of greater than 20% of the Company’s outstanding securities under Rule
4350(i) be obtained pursuant to Rule 4350(i)(2), such date shall be extended to
September 28, 2007.

2

 

	 	(c)	 	Parent agrees that the listing of work-in-process, raw and packaging materials,
and service, replacement and accessory parts used to build the Gemini, Venus, Aura,
Lyra and Solis products (subject to the last sentence in this Section 2(c), the “Parts
Inventory”) attached hereto as Exhibit C accurately represents the item
numbers, product classifications and the actual unit costs thereof. Purchaser will
receive 63.4% of all parts included in the Parts Inventory that are identified as
“Greenlight/Gemini Common” in Exhibit C and 100% of all other parts included in
the Parts Inventory. Seller will deliver the Parts Inventory to Purchaser at Seller’s
facility in San Jose, California by part and quantity requested by Purchaser at
mutually agreeable times during the remaining term of the PSA; provided, however, that
Seller shall retain possession of such Parts Inventory as is necessary to allow it to
build Products to be delivered to Seller under the purchase orders referred to in
Section 2(a) after termination or expiration of the PSA and shall deliver any such
remaining Parts Inventory after delivery such Products. Title to the Parts Inventory
shall pass to Purchaser upon the earlier of delivery of such inventory to Purchaser or
termination or expiration of the PSA. Purchaser shall confirm the parts and quantities
of Parts Inventory being delivered at the time of delivery at Seller’s facility in San
Jose, California. Except as set forth in the preceding sentence, a physical count of
the Inventory contemplated by Section 7.3(c) of the PSA will not be conducted.
Notwithstanding anything in this Agreement or the PSA to the contrary, the Parts
Inventory does not include, and Seller will not sell to Purchaser, such quantity of
work-in-process, and raw materials sufficient to allow Seller to build up to 35 Aura
products, and Seller shall retain ownership and possession of such items that would
otherwise be included in the definition of Parts Inventory but for this sentence, even
though such items are included in the quantities set forth on Exhibit C.
	 
	 	(d)	 	The pricing currently in effect under the PSA will remain in effect for the
duration of the PSA and for purchase of Products and Parts Inventory thereafter
notwithstanding anything to the contrary in Section 3.1 of the PSA. For purposes of
clarity, the pricing currently in effect does not include the 20% markup referred to in
Section 3.1 of the PSA.
	 
	 	(e)	 	The PSA shall terminate on October 16, 2007 unless terminated earlier in
accordance with the provisions of the PSA, as amended by this Settlement Agreement.
Notwithstanding the foregoing sentence, the provisions of Sections 2.5, 2.6, 2.8,
2.10, 5.1 and 5.2 of the PSA shall continue to apply to Products (if any) sold to
Purchaser after the termination of the PSA pursuant to the purchase orders referred to
in Section 2(a). Section 7.1 of the PSA is hereby amended to reflect the foregoing
sentences.
	 
	 	(f)	 	The purchase price for the Product Inventory (as defined in the PSA) to be
purchased by Purchaser pursuant to Section 7.3(c) of the PSA after the expiration or
termination of the PSA shall be $4,059,557 (the “Final Product Inventory Payment”),
consisting of:

3

 

	 	(i)	 	$3,700,000 (the “Parts Inventory Amount”) for
Parts Inventory delivered upon or prior to expiration or termination of
the PSA, and;
	 
	 	(ii)	 	$359,557 for service parts delivered on or
about March 9, 2007.

	 	 	 	Subject to subsections (g) and (h) below, the Final Product Inventory Payment shall
be payable in thirty-nine (39) equal weekly installments, beginning on January
3, 2008 and continuing on the Thursday of each week thereafter through and
including September 25, 2008, in the amount of $110,185, which includes
interest on the unpaid balance of the Final Product Inventory Payment at the
rate of 10% per annum from the date that the PSA terminates or expires. If any
scheduled payment date is not a business day, then the applicable payment will
be due on the first business day thereafter. All payments shall be made by
wire transfer of immediately available funds.
	 
	 	(g)	 	In the event that Purchaser increases its Borrowing Capacity (as defined below)
under any credit facility that is senior to Purchaser’s payment obligations hereunder
to Seller, either with its current senior lender, Mid-Peninsula Bank — part of Greater
Bay Bank N.A, or any subsequent senior lender, to more than $12 million (the amount of
Borrowing Capacity in excess of $12 million being the “Increased Capacity”), either
prior to Purchaser’s acquisition of the Product Inventory or at any time thereafter
while payments are due under Sections 1(b) or 2(f), then Purchaser shall pay at the
time of acquisition of the Product Inventory, or if such Increased Capacity becomes
available after the date of such acquisition, then at the time such Increased Capacity
becomes available, an amount equal to 50% of such Increased Capacity. Such payment
shall be applied to the payments otherwise due under Sections 1(b) or 2(f) in the
inverse order of maturity beginning with the last payment then due. “Borrowing
Capacity” shall mean the maximum amount that Purchaser is permitted to borrow under its
credit facility then in effect, less (i) any amount that is not available to borrow due
to borrowing base limitations under the credit facility and (ii) any minimum cash
restriction imposed by the lender, including segregated cash deposits or other balances
that must be maintained at the lender.
	 
	 	(h)	 	Notwithstanding the foregoing subsections (f) and (g), in the event that the
date on which Seller is obligated to sell the Product Inventory to Purchaser under
Section 7.3(c) of the PSA occurs in a Payment Blockage Period (as defined in the
Subordination Agreement by and between Mid-Peninsula Bank — part of Greater Bay Bank
N.A, Parent, Seller and Purchaser dated the date hereof (the “Subordination
Agreement”)), then Purchaser agrees to pay to Seller the entire purchase price for the
Product Inventory purchased pursuant to Section 7.3(c) within three (3) business days
from the date of sale or as soon thereafter as permitted by the Subordination
Agreement.
	 
	 	(i)	 	Section 7.3(c)(ii) of the PSA is hereby deleted from the PSA and shall be of no
further force or effect.

4

 

	 	(j)	 	Simultaneously with the execution and delivery of this Settlement Agreement,
Seller is executing and delivering to Purchaser a signed representation letter to
Purchaser’s independent registered public accountants, which such representation letter
is attached as Exhibit D hereto.
	 
	 	(k)	 	The above sections (a) — (j) constitute an amendment to the PSA under Section
9.3(a) of the PSA.

     3.       Cross-Default.

	 	(a)	 	The occurrence of an Event of Default under the terms of the
Senior Debt (as defined in the Subordination Agreement) or any other agreement
between the Purchaser and the lender of the Purchaser’s senior debt, which is
not cured by Purchaser within the applicable cure period or waived by such
lender within 30 days, or the issuance of a Payment Blockage Notice (as defined
in the Subordination Agreement) to Seller shall be deemed to be a breach of
this Settlement Agreement.
	 
	 	(b)	 	Simultaneously with the execution of this Settlement Agreement,
Purchaser is entering into a security agreement with Seller and Parent (the
“Security Agreement”). Any breach by Purchaser of any provision of this
Settlement Agreement, the Letter Agreement or the occurrence of an Event of
Default under the Security Agreement shall constitute an immediate default
under both the Security Agreement and PSA and the thirty (30) day cure period
referenced under Section 7.2(b) of the PSA shall not apply. Any breach of this
Settlement Agreement, the Letter Agreement or the PSA or the occurrence of an
Event of Default under the Security Agreement shall, subject to the terms of
the Subordination Agreement, entitle Parent and Seller to any and all remedies
available to them under the Security Agreement, the PSA, this Settlement
Agreement, at law and in equity, including, but not limited to, the right to
terminate the PSA immediately upon written notice to Purchaser with no
additional notice period or opportunity to cure and the right to declare all
amounts due hereunder and the Letter Agreement to be immediately due and
payable in full.

     4.       French Personnel. Purchaser agrees to pay 50% of Parent’s (or its affiliate’s) out
of pocket costs, including severance costs and reasonable attorneys’ fees, relating to the
termination of the employment of Kristine Hautekiet. The parties acknowledge that Parent’s
affiliate will implement such termination. Such amount will be paid by Purchaser within fifteen
days of Parent delivering a request for such payment along with supporting documentation.

     5.       Parent and Seller Release; Parent and Seller Representations and Warranties.

	 	(a)	 	Except with respect to payments due hereunder or the Letter Agreement or
breaches of this Settlement Agreement, each of Parent and Seller, for and on behalf of
itself and its employees, officers, directors, shareholders, affiliates,

5

 

	 	 	 	representatives, predecessors, successors and assigns (collectively, the “Seller
Releasing Parties”), hereby fully and forever release and discharge Purchaser and
its affiliates from any and all claims, liabilities, demands, damages, rights,
actions or causes of action, whether fixed or contingent, liquidated or
unliquidated, direct or indirect, known or unknown (“Claims”), which any Seller
Releasing Party has or may have in any way relating to, arising out of, or involving
(i) any amounts due any Seller Releasing Party under Sections 1.4 or 1.5 of the
Purchase Agreement or (ii) any amounts due any Seller Releasing Party under the PSA
or any other violations or breaches thereof.

	 	(b)	 	Parent and Seller represent and warrant to the Purchaser Releasing Parties (as
defined below) that, as of the date hereof, neither Parent nor Seller has (i) any claim
for indemnification under Section 8.3 of the Purchase Agreement, the Asset Purchase
Agreement dated December 30, 2006 by and between Laserscope (UK) Limited and American
Medical Systems UK Limited (the “UK Asset Purchase Agreement”), or the Asset Purchase
Agreement dated December 30, 2006 by and between Laserscope France Limited and American
Medical Systems France (the “French Asset Purchase Agreement”) or (ii) knowledge of any
events, facts or circumstances that would give rise to, or with the passage of time
would give rise to, a claim for indemnification under any of the foregoing agreements.
Parent and Seller acknowledge and agree that the Purchaser Releasing Parties’ damages
for any breach of the foregoing sentence will be equal in amount to the damages arising
out of any claim that Parent or Seller makes under Section 8.3 of the Purchase
Agreement, the UK Asset Purchase Agreement or the French Asset Purchase Agreement that
constitutes a breach of the foregoing sentence. Parent and Seller agree that the
survival period set forth in the first sentence of Section 8.1 of the Purchase
Agreement with respect to the representations and warranties made by Purchaser in
Article III of the Purchase Agreement shall expire on the date hereof, and that neither
Parent nor Seller will have any right to make a claim for indemnification under Article
VIII of the Purchase Agreement based on a breach of any representation or warranty by
Purchaser in Article III of the Purchase Agreement; provided that the representations
and warranties referred to in clause (a) of the second sentence of Section 8.1, and the
right to make a claim for any breach thereof, shall survive for the time periods set
forth therein. The provisions of this Settlement Agreement shall not impact or alter
Parent’s or Seller’s rights set forth in the Purchase Agreement, or otherwise, with
respect to Fraud Claims (as defined in the Purchase Agreement) or breaches of covenants
contained in the Purchase Agreement, in each case that are unknown by Parent and Seller
as of the date hereof or occur after the date hereof, or their ability to make claims
in connection therewith.

     6.       Purchaser Release; Purchaser Representations and Warranties.

	 	(a)	 	Except with respect to payments due hereunder or breaches of this Settlement
Agreement, Purchaser, for and on behalf of itself and its employees, officers,
directors, shareholders, affiliates, representatives, predecessors, successors and
assigns (collectively, the “Purchaser Releasing Parties”), hereby fully and forever

6

 

	 	 	 	releases and discharges the Seller Releasing Parties from any and all Claims, which
any Purchaser Releasing Party has or may have in any way relating to, arising out
of, or involving:

	 	(i)	 	any amounts due any Purchaser Releasing Party under Sections
1.4 or 1.5 of the Purchase Agreement;
	 
	 	(ii)	 	any breach or alleged breach by a Seller Releasing Party of
Section 2.6, 2.7, 2.9 and/or 4.4(g) of the Purchase Agreement, regardless of
whether any Purchaser Released Party knew, knows or should have known of such
breach, and regardless of whether the breach occurred or occurs or is alleged
to occur or have occurred before, on or after the date hereof;
	 
	 	(iii)	 	any claim for indemnification under Section 8.2 of the
Purchase Agreement, the UK Asset Purchase Agreement, or the French Asset
Purchase Agreement, in each case to the extent related to the matters referred
to in clauses (i) — (ii) above; or
	 
	 	(iv)	 	any amounts due any Purchaser Releasing Party under the PSA for
any violations or breaches by a Seller Releasing Party thereof.

	 	(b)	 	Purchaser represents and warrants to the Seller Releasing Parties that, as of
the date hereof, Purchaser does not have (i) any claim for indemnification under
Section 8.2 of the Purchase Agreement, the UK Asset Purchase Agreement or the French
Asset Purchase Agreement or (ii) knowledge of any events, facts or circumstances that
would give rise to, or with the passage of time would give rise to, a claim for
indemnification under any of the foregoing agreements. Purchaser acknowledges and
agrees that the Seller Releasing Parties’ damages for any breach of the foregoing
sentence will be equal in amount to the damages arising out of any claim that Purchaser
makes under Section 8.2 of the Purchase Agreement, the UK Asset Purchase Agreement or
the French Asset Purchase Agreement that constitutes a breach of the foregoing
sentence. Purchaser agrees that the survival period set forth in the first sentence of
Section 8.1 of the Purchase Agreement with respect to the representations and
warranties made by Parent and Seller in Article II of the Purchase Agreement shall
expire on the date hereof, and that Purchaser will not have any right to make a claim
for indemnification under Article VIII of the Purchase Agreement based on a breach of
any representation or warranty by Parent or Seller in Article II of the Purchase
Agreement; provided that the representations and warranties referred to in clauses (a)
and (b) of the second sentence of Section 8.1, and the right to make a claim for any
breach thereof, shall survive for the time periods set forth therein. The provisions
of this Settlement Agreement shall not impact or alter Purchaser’s rights set forth in
the Purchase Agreement, or otherwise, with respect to Fraud Claims or breaches of
covenants contained in the Purchase Agreement, in each case that are unknown by
Purchaser as of the date hereof or occur after the date hereof, or its ability to make
claims in connection therewith.

7

 

     7.       Security Interest; Permitted Exception to Non-Compete Covenant. Upon execution of
this Settlement Agreement, Purchaser shall execute and deliver to Parent and Seller a Security
Agreement in form and content satisfactory to Parent and Seller under which Purchaser is granting
to Parent and Seller, subject to the terms of the Subordination Agreement, a security interest in
all of Purchaser’s assets to secure all of its current and future obligations to Seller. In the
event that Parent and/or Seller takes possession of, or acquires any rights in, any Products or
Product Inventory sold to Purchaser, or any other assets of Purchaser whether pursuant to the
Security Agreement or otherwise, or in the event any Product Inventory that Purchaser is obligated
to purchase under Section 7.3 of the PSA is not so purchased in accordance with the terms of the
PSA as modified by this Settlement Agreement, then Parent, Seller and/or the affiliate of either of
them shall be entitled, subject to Article 9 of the Uniform Commercial Code and the terms of the
Subordination Agreement, to market and sell such Products and/or Product Inventory and/or assets,
or otherwise utilize, transfer or dispose of such items, in any manner that Parent, Seller and/or
the affiliate of either of them determines. Any such utilization, marketing, sale, transfer or
disposition, or any activity reasonably related thereto, will not be considered a violation or
breach of Section 4.4(b) of the Purchase Agreement, and Purchaser agrees it will not seek to
enforce the provisions of such Section 4.4(b) in connection with any such actions by Parent, Seller
and/or the affiliate of either of them.

     8.       Full Awareness. Each of the Parties hereto warrants, represents and agrees that it
is entering into this Settlement Agreement with full knowledge of the terms and provisions of this
Settlement Agreement.

     9.       Authority. Each of the Parties hereto represents and warrants that said Party has
the full authority to enter into this Settlement Agreement, and that the individuals who are
executing this Settlement Agreement on behalf of that Party are authorized to do so and to bind
that Party (and that Party’s affiliates) to the terms and conditions of this Settlement Agreement.

     10.       Binding Effect. This Settlement Agreement is binding upon and shall inure to the
benefit of the licensees, representatives, employees, officers, transferees, affiliates,
subsidiaries, parent corporations, successors, heirs and/or assigns of the Parties hereto.

     11.       Entire Agreement. This Settlement Agreement, the Letter Agreement and the
Purchase Agreement contain the entire agreement between the Parties hereto with respect to the
subject matter hereof, supersedes any and all prior oral and written agreements relating thereto,
and may not be modified, amended or amplified except by a written document executed by the Parties
hereto.

     12.       Governing Law. This Settlement Agreement shall be governed by the laws of the
State of Minnesota.

     13.       Severability. If any provision of this Settlement Agreement is invalid and
unenforceable in any jurisdiction then, to the fullest extent permitted by law, (a) the other
provisions hereof shall remain in full force and effect in such jurisdiction, and (b) the
invalidity or unenforceability of any provision hereof in any jurisdiction shall not affect the
validity or enforceability of such provision in any other jurisdiction.

8

 

     14.       Counterparts. This Settlement Agreement may be executed in one or more
counterparts, each of which shall be deemed an original, but all of which shall constitute one and
the same instrument. The Parties agree that delivery by facsimile of executed signature pages
shall be deemed execution of this Settlement Agreement. All facsimile signatures of this
Settlement Agreement shall be deemed originals for all purposes.

***Remainder of Page Intentionally Left Blank***

9

 

     IN WITNESS WHEREOF, the Parties hereto have executed this Settlement Agreement as of the date
first above written.

	 	 	 	 	 
	IRIDEX CORPORATION	 	
LASERSCOPE
	By:	 	 	By:
	 	 

Name:	 	 	 

Name:
	 	Title	 	 	
Title

	 	 	 	 	 
	 	AMERICAN MEDICAL SYSTEMS, INC.

 	 
	 	By:  	 
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

 

 

Exhibit A

Purchase Orders

See attached

 

 

Exhibit B

Hand Pieces and Service Parts

See attached

 

 

Exhibit C

Work-in-process, Raw and Packaging Materials, and Service, Replacement and Accessory Parts

See attached

 

 

Exhibit D

Form of Representation Letter

See attached

 

 

Schedule 1.6

Asset Allocation

See attached

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00128-of-00352.parquet"}]]